Arbutus Biopharma Corp (ABUS)
3.63
-0.02
(-0.55%)
USD |
NASDAQ |
Nov 14, 16:00
3.65
+0.02
(+0.55%)
After-Hours: 04:13
Arbutus Biopharma Free Cash Flow (Quarterly): -20.74M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -20.74M |
| June 30, 2024 | -14.50M |
| March 31, 2024 | -19.39M |
| December 31, 2023 | -17.29M |
| September 30, 2023 | -21.82M |
| June 30, 2023 | -20.42M |
| March 31, 2023 | -27.42M |
| December 31, 2022 | -17.12M |
| September 30, 2022 | -18.78M |
| June 30, 2022 | -20.50M |
| March 31, 2022 | 20.54M |
| December 31, 2021 | -19.66M |
| September 30, 2021 | -16.06M |
| June 30, 2021 | -14.64M |
| March 31, 2021 | -17.98M |
| December 31, 2020 | -15.16M |
| September 30, 2020 | -12.18M |
| June 30, 2020 | -8.867M |
| March 31, 2020 | -15.45M |
| December 31, 2019 | -13.41M |
| September 30, 2019 | -23.72M |
| June 30, 2019 | -17.84M |
| March 31, 2019 | -16.61M |
| December 31, 2018 | -17.30M |
| September 30, 2018 | -13.44M |
| Date | Value |
|---|---|
| June 30, 2018 | -18.05M |
| March 31, 2018 | -20.22M |
| December 31, 2017 | -10.53M |
| September 30, 2017 | -16.22M |
| June 30, 2017 | -8.198M |
| March 31, 2017 | -20.96M |
| December 31, 2016 | -17.42M |
| September 30, 2016 | -14.88M |
| June 30, 2016 | -17.76M |
| March 31, 2016 | -11.82M |
| December 31, 2015 | -19.39M |
| September 30, 2015 | -3.116M |
| June 30, 2015 | -18.18M |
| March 31, 2015 | -17.98M |
| December 31, 2014 | -7.169M |
| September 30, 2014 | -6.872M |
| June 30, 2014 | -8.256M |
| March 31, 2014 | 8.82M |
| December 31, 2013 | 2.373M |
| September 30, 2013 | -3.79M |
| June 30, 2013 | -3.004M |
| March 31, 2013 | -3.041M |
| December 31, 2012 | 40.36M |
| September 30, 2012 | -1.514M |
| June 30, 2012 | -1.686M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-27.42M
Minimum
Mar 2023
20.54M
Maximum
Mar 2022
-15.54M
Average
-17.21M
Median
Free Cash Flow (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 200.30M |
| Amicus Therapeutics Inc | -23.33M |
| Ionis Pharmaceuticals Inc | -111.30M |
| GlycoMimetics Inc | -8.896M |
| FibroGen Inc | -39.88M |